Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genesco (GCO) Cash & Equivalents (2016 - 2025)

Genesco (GCO) has 16 years of Cash & Equivalents data on record, last reported at $27.0 million in Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 19.49% year-over-year to $27.0 million; the TTM value through Nov 2025 reached $27.0 million, down 19.49%, while the annual FY2025 figure was $34.0 million, N/A changed from the prior year.
  • Cash & Equivalents reached $27.0 million in Q4 2025 per GCO's latest filing, down from $41.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $320.5 million in Q1 2022 and bottomed at $19.2 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $97.9 million, with a median of $39.2 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 164.18% in 2021, then tumbled 88.64% in 2022.
  • A 5-year view of Cash & Equivalents shows it stood at $282.8 million in 2021, then crashed by 88.64% to $32.1 million in 2022, then crashed by 32.45% to $21.7 million in 2023, then surged by 54.8% to $33.6 million in 2024, then dropped by 19.49% to $27.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $27.0 million in Q4 2025, $41.0 million in Q3 2025, and $21.7 million in Q2 2025.